View Future GrowthFumakilla 過去の業績過去 基準チェック /26Fumakillaは、平均年間0.8%の収益成長を遂げていますが、 Chemicals業界の収益は、年間 成長しています。収益は、平均年間5.4% 9.5%収益成長率で 成長しています。 Fumakillaの自己資本利益率は4.8%であり、純利益率は1.6%です。主要情報0.78%収益成長率0.78%EPS成長率Chemicals 業界の成長6.58%収益成長率9.46%株主資本利益率4.80%ネット・マージン1.56%前回の決算情報31 Mar 2026最近の業績更新Reported Earnings • May 18Full year 2026 earnings released: EPS: JP¥73.18 (vs JP¥88.72 in FY 2025)Full year 2026 results: EPS: JP¥73.18 (down from JP¥88.72 in FY 2025). Revenue: JP¥77.4b (up 4.8% from FY 2025). Net income: JP¥1.21b (down 18% from FY 2025). Profit margin: 1.6% (down from 2.0% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.お知らせ • May 09Fumakilla Limited to Report Fiscal Year 2026 Results on May 14, 2026Fumakilla Limited announced that they will report fiscal year 2026 results on May 14, 2026Reported Earnings • Feb 11Third quarter 2026 earnings released: JP¥45.02 loss per share (vs JP¥32.22 loss in 3Q 2025)Third quarter 2026 results: JP¥45.02 loss per share (further deteriorated from JP¥32.22 loss in 3Q 2025). Revenue: JP¥14.8b (up 15% from 3Q 2025). Net loss: JP¥742.0m (loss widened 40% from 3Q 2025). Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.Reported Earnings • Nov 12Second quarter 2026 earnings released: EPS: JP¥48.30 (vs JP¥2.00 in 2Q 2025)Second quarter 2026 results: EPS: JP¥48.30 (up from JP¥2.00 in 2Q 2025). Revenue: JP¥19.3b (down 1.6% from 2Q 2025). Net income: JP¥796.0m (up JP¥763.0m from 2Q 2025). Profit margin: 4.1% (up from 0.2% in 2Q 2025). The increase in margin was driven by lower expenses. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.お知らせ • Oct 02Fumakilla Limited to Report Q2, 2026 Results on Nov 10, 2025Fumakilla Limited announced that they will report Q2, 2026 results on Nov 10, 2025Reported Earnings • Aug 10First quarter 2026 earnings released: EPS: JP¥32.16 (vs JP¥43.02 in 1Q 2025)First quarter 2026 results: EPS: JP¥32.16 (down from JP¥43.02 in 1Q 2025). Revenue: JP¥20.8b (flat on 1Q 2025). Net income: JP¥530.0m (down 25% from 1Q 2025). Profit margin: 2.5% (down from 3.4% in 1Q 2025). Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.すべての更新を表示Recent updatesReported Earnings • May 18Full year 2026 earnings released: EPS: JP¥73.18 (vs JP¥88.72 in FY 2025)Full year 2026 results: EPS: JP¥73.18 (down from JP¥88.72 in FY 2025). Revenue: JP¥77.4b (up 4.8% from FY 2025). Net income: JP¥1.21b (down 18% from FY 2025). Profit margin: 1.6% (down from 2.0% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.お知らせ • May 14Fumakilla Limited, Annual General Meeting, Jun 26, 2026Fumakilla Limited, Annual General Meeting, Jun 26, 2026.お知らせ • May 09Fumakilla Limited to Report Fiscal Year 2026 Results on May 14, 2026Fumakilla Limited announced that they will report fiscal year 2026 results on May 14, 2026Upcoming Dividend • Mar 23Upcoming dividend of JP¥24.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 30 June 2026. Payout ratio is a comfortable 20% but the company is not cash flow positive. Trailing yield: 2.1%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (2.3%).New Risk • Feb 28New major risk - Revenue and earnings growthEarnings have declined by 6.0% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.0% per year over the past 5 years. Minor Risk Paying a dividend despite having no free cash flows.Reported Earnings • Feb 11Third quarter 2026 earnings released: JP¥45.02 loss per share (vs JP¥32.22 loss in 3Q 2025)Third quarter 2026 results: JP¥45.02 loss per share (further deteriorated from JP¥32.22 loss in 3Q 2025). Revenue: JP¥14.8b (up 15% from 3Q 2025). Net loss: JP¥742.0m (loss widened 40% from 3Q 2025). Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.分析記事 • Jan 08Fumakilla (TSE:4998) Has Announced That It Will Be Increasing Its Dividend To ¥24.00Fumakilla Limited ( TSE:4998 ) has announced that it will be increasing its dividend from last year's comparable...Declared Dividend • Jan 08Dividend of JP¥24.00 announcedShareholders will receive a dividend of JP¥24.00. Ex-date: 30th March 2026 Payment date: 30th June 2026 Dividend yield will be 2.1%, which is lower than the industry average of 2.2%. Sustainability & Growth Dividend is covered by earnings (18% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.1% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 39% over the next 3 years, which should provide support to the dividend and adequate earnings cover.お知らせ • Jan 07Fumakilla Limited announces Annual dividend, payable on June 30, 2026Fumakilla Limited announced Annual dividend of JPY 24.0000 per share payable on June 30, 2026, ex-date on March 30, 2026 and record date on March 31, 2026.Reported Earnings • Nov 12Second quarter 2026 earnings released: EPS: JP¥48.30 (vs JP¥2.00 in 2Q 2025)Second quarter 2026 results: EPS: JP¥48.30 (up from JP¥2.00 in 2Q 2025). Revenue: JP¥19.3b (down 1.6% from 2Q 2025). Net income: JP¥796.0m (up JP¥763.0m from 2Q 2025). Profit margin: 4.1% (up from 0.2% in 2Q 2025). The increase in margin was driven by lower expenses. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.お知らせ • Oct 02Fumakilla Limited to Report Q2, 2026 Results on Nov 10, 2025Fumakilla Limited announced that they will report Q2, 2026 results on Nov 10, 2025Reported Earnings • Aug 10First quarter 2026 earnings released: EPS: JP¥32.16 (vs JP¥43.02 in 1Q 2025)First quarter 2026 results: EPS: JP¥32.16 (down from JP¥43.02 in 1Q 2025). Revenue: JP¥20.8b (flat on 1Q 2025). Net income: JP¥530.0m (down 25% from 1Q 2025). Profit margin: 2.5% (down from 3.4% in 1Q 2025). Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.お知らせ • Jun 29Fumakilla Limited to Report Q1, 2026 Results on Aug 08, 2025Fumakilla Limited announced that they will report Q1, 2026 results on Aug 08, 2025Reported Earnings • May 18Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: JP¥88.72 (up from JP¥83.56 in FY 2024). Revenue: JP¥73.9b (up 9.1% from FY 2024). Net income: JP¥1.46b (up 6.2% from FY 2024). Profit margin: 2.0% (in line with FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 11%. Revenue is forecast to grow 5.3% p.a. on average during the next 2 years, compared to a 4.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.お知らせ • May 14Fumakilla Limited, Annual General Meeting, Jun 27, 2025Fumakilla Limited, Annual General Meeting, Jun 27, 2025.お知らせ • May 01Fumakilla Limited to Report Fiscal Year 2025 Results on May 14, 2025Fumakilla Limited announced that they will report fiscal year 2025 results on May 14, 2025Upcoming Dividend • Mar 21Upcoming dividend of JP¥22.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 28 June 2025. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of Japanese dividend payers (3.7%). Lower than average of industry peers (2.6%).Reported Earnings • Feb 12Third quarter 2025 earnings released: JP¥32.22 loss per share (vs JP¥52.18 loss in 3Q 2024)Third quarter 2025 results: JP¥32.22 loss per share (improved from JP¥52.18 loss in 3Q 2024). Revenue: JP¥12.9b (down 2.7% from 3Q 2024). Net loss: JP¥531.0m (loss narrowed 38% from 3Q 2024). Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.お知らせ • Jan 17Fumakilla Limited to Report Q3, 2025 Results on Feb 10, 2025Fumakilla Limited announced that they will report Q3, 2025 results on Feb 10, 2025Reported Earnings • Nov 10Second quarter 2025 earnings released: EPS: JP¥2.00 (vs JP¥24.33 in 2Q 2024)Second quarter 2025 results: EPS: JP¥2.00 (down from JP¥24.33 in 2Q 2024). Revenue: JP¥19.6b (up 9.7% from 2Q 2024). Net income: JP¥33.0m (down 92% from 2Q 2024). Profit margin: 0.2% (down from 2.2% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.お知らせ • Sep 28Fumakilla Limited to Report Q2, 2025 Results on Nov 08, 2024Fumakilla Limited announced that they will report Q2, 2025 results on Nov 08, 2024Reported Earnings • Aug 13First quarter 2025 earnings released: EPS: JP¥43.02 (vs JP¥30.10 in 1Q 2024)First quarter 2025 results: EPS: JP¥43.02 (up from JP¥30.10 in 1Q 2024). Revenue: JP¥20.9b (up 9.0% from 1Q 2024). Net income: JP¥709.0m (up 43% from 1Q 2024). Profit margin: 3.4% (up from 2.6% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 8% per year.お知らせ • Jun 30Fumakilla Limited to Report Q1, 2025 Results on Aug 09, 2024Fumakilla Limited announced that they will report Q1, 2025 results on Aug 09, 2024Major Estimate Revision • Jun 22Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from JP¥69.4b to JP¥75.0b. EPS estimate fell from JP¥115 to JP¥100 per share. Net income forecast to grow 20% next year vs 11% growth forecast for Chemicals industry in Japan. Consensus price target up from JP¥1,365 to JP¥1,500. Share price was steady at JP¥1,198 over the past week.Price Target Changed • Jun 21Price target increased by 14% to JP¥1,500Up from JP¥1,320, the current price target is provided by 1 analyst. New target price is 25% above last closing price of JP¥1,198. Stock is up 5.7% over the past year. The company is forecast to post earnings per share of JP¥100 for next year compared to JP¥83.55 last year.Reported Earnings • May 21Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2024 results: EPS: JP¥83.55 (up from JP¥40.53 in FY 2023). Revenue: JP¥67.7b (up 9.7% from FY 2023). Net income: JP¥1.38b (up 106% from FY 2023). Profit margin: 2.0% (up from 1.1% in FY 2023). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.0%. Earnings per share (EPS) missed analyst estimates by 8.2%. Revenue is forecast to grow 2.7% p.a. on average during the next 2 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.New Risk • May 21New major risk - Revenue and earnings growthEarnings have declined by 3.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 3.2% per year over the past 5 years. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.お知らせ • May 17Fumakilla Limited, Annual General Meeting, Jun 27, 2024Fumakilla Limited, Annual General Meeting, Jun 27, 2024.お知らせ • Mar 28Fumakilla Limited to Report Fiscal Year 2024 Results on May 15, 2024Fumakilla Limited announced that they will report fiscal year 2024 results on May 15, 2024Upcoming Dividend • Mar 21Upcoming dividend of JP¥22.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 01 July 2024. Payout ratio is a comfortable 25% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of Japanese dividend payers (3.2%). In line with average of industry peers (2.1%).Reported Earnings • Feb 10Third quarter 2024 earnings released: JP¥52.18 loss per share (vs JP¥81.55 loss in 3Q 2023)Third quarter 2024 results: JP¥52.18 loss per share (improved from JP¥81.55 loss in 3Q 2023). Revenue: JP¥13.2b (up 12% from 3Q 2023). Net loss: JP¥860.0m (loss narrowed 36% from 3Q 2023). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.Reported Earnings • Feb 10Third quarter 2024 earnings released: JP¥52.18 loss per share (vs JP¥81.55 loss in 3Q 2023)Third quarter 2024 results: JP¥52.18 loss per share (improved from JP¥81.55 loss in 3Q 2023). Revenue: JP¥13.2b (up 12% from 3Q 2023). Net loss: JP¥860.0m (loss narrowed 36% from 3Q 2023). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.お知らせ • Jan 31Fumakilla Limited to Report Q3, 2024 Results on Feb 09, 2024Fumakilla Limited announced that they will report Q3, 2024 results on Feb 09, 2024Reported Earnings • Nov 11Second quarter 2024 earnings released: EPS: JP¥24.33 (vs JP¥7.34 in 2Q 2023)Second quarter 2024 results: EPS: JP¥24.33 (up from JP¥7.34 in 2Q 2023). Revenue: JP¥17.9b (up 12% from 2Q 2023). Net income: JP¥401.0m (up 231% from 2Q 2023). Profit margin: 2.2% (up from 0.8% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.お知らせ • Oct 05Fumakilla Limited to Report Q2, 2024 Results on Nov 10, 2023Fumakilla Limited announced that they will report Q2, 2024 results on Nov 10, 2023Major Estimate Revision • Aug 25Consensus EPS estimates fall by 17%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from JP¥106 to JP¥88.00 per share. Revenue forecast steady at JP¥64.5b. Net income forecast to grow 117% next year vs 7.6% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥1,480 to JP¥1,320. Share price rose 2.5% to JP¥1,107 over the past week.Reported Earnings • Aug 12First quarter 2024 earnings released: EPS: JP¥30.10 (vs JP¥28.03 in 1Q 2023)First quarter 2024 results: EPS: JP¥30.10 (up from JP¥28.03 in 1Q 2023). Revenue: JP¥19.2b (up 3.7% from 1Q 2023). Net income: JP¥496.0m (up 7.4% from 1Q 2023). Profit margin: 2.6% (in line with 1Q 2023). Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.Buying Opportunity • Aug 10Now 24% undervaluedOver the last 90 days, the stock is up 3.5%. The fair value is estimated to be JP¥1,464, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has declined by 40%. For the next 3 years, revenue is forecast to grow by 3.1% per annum. Earnings is also forecast to grow by 28% per annum over the same time period.お知らせ • Jul 10Fumakilla Limited to Report Q1, 2024 Results on Aug 10, 2023Fumakilla Limited announced that they will report Q1, 2024 results on Aug 10, 2023Reported Earnings • May 21Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: JP¥40.53 (down from JP¥84.40 in FY 2022). Revenue: JP¥61.7b (up 17% from FY 2022). Net income: JP¥668.0m (down 52% from FY 2022). Profit margin: 1.1% (down from 2.6% in FY 2022). Revenue missed analyst estimates by 4.3%. Earnings per share (EPS) also missed analyst estimates by 33%. Revenue is forecast to grow 6.2% p.a. on average during the next 2 years, compared to a 3.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.お知らせ • May 14Fumakilla Limited, Annual General Meeting, May 15, 2023Fumakilla Limited, Annual General Meeting, May 15, 2023.Upcoming Dividend • Mar 23Upcoming dividend of JP¥22.00 per share at 2.1% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 27 June 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.1%. Lower than top quartile of Japanese dividend payers (3.6%). Lower than average of industry peers (2.8%).Reported Earnings • Feb 17Third quarter 2023 earnings released: JP¥81.54 loss per share (vs JP¥46.84 loss in 3Q 2022)Third quarter 2023 results: JP¥81.54 loss per share (further deteriorated from JP¥46.84 loss in 3Q 2022). Revenue: JP¥11.9b (up 32% from 3Q 2022). Net loss: JP¥1.34b (loss widened 74% from 3Q 2022). Revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.お知らせ • Dec 31Fumakilla Limited to Report Q3, 2023 Results on Feb 10, 2023Fumakilla Limited announced that they will report Q3, 2023 results on Feb 10, 2023Major Estimate Revision • Dec 23Consensus forecasts updatedThe consensus outlook for 2023 has been updated. 2023 revenue forecast increased from JP¥63.0b to JP¥64.5b. EPS estimate fell from JP¥77.10 to JP¥60.70 per share. Net income forecast to grow 82% next year vs 0.7% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥1,310 to JP¥1,200. Share price was steady at JP¥1,034 over the past week.Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: JP¥7.34 (vs JP¥4.19 in 2Q 2022)Second quarter 2023 results: EPS: JP¥7.34 (up from JP¥4.19 in 2Q 2022). Revenue: JP¥16.0b (up 48% from 2Q 2022). Net income: JP¥121.0m (up 75% from 2Q 2022). Profit margin: 0.8% (up from 0.6% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.1% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. 5 highly experienced directors. No independent directors (11 non-independent directors). General Manager of Production Division, Manager of Hiroshima Plant and Director Hiroaki Inoue was the last director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.Reported Earnings • Nov 13Second quarter 2023 earnings released: EPS: JP¥7.34 (vs JP¥4.19 in 2Q 2022)Second quarter 2023 results: EPS: JP¥7.34 (up from JP¥4.19 in 2Q 2022). Revenue: JP¥16.0b (up 48% from 2Q 2022). Net income: JP¥121.0m (up 75% from 2Q 2022). Profit margin: 0.8% (up from 0.6% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.1% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.お知らせ • Sep 03Fumakilla Limited to Report Q2, 2023 Results on Nov 11, 2022Fumakilla Limited announced that they will report Q2, 2023 results on Nov 11, 2022Major Estimate Revision • Aug 30Consensus EPS estimates fall by 19%The consensus outlook for earnings per share (EPS) in 2023 has deteriorated. 2023 revenue forecast decreased from JP¥64.5b to JP¥63.0b. EPS estimate also fell from JP¥94.70 per share to JP¥77.10 per share. Net income forecast to grow 104% next year vs 2.5% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥1,520 to JP¥1,310. Share price was steady at JP¥1,095 over the past week.Reported Earnings • Aug 11First quarter 2023 earnings released: EPS: JP¥28.03 (vs JP¥69.66 in 1Q 2022)First quarter 2023 results: EPS: JP¥28.03 (down from JP¥69.66 in 1Q 2022). Revenue: JP¥18.5b (up 6.8% from 1Q 2022). Net income: JP¥462.0m (down 60% from 1Q 2022). Profit margin: 2.5% (down from 6.6% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 21%, compared to a 9.2% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.お知らせ • Jul 02Fumakilla Limited to Report Q1, 2023 Results on Aug 09, 2022Fumakilla Limited announced that they will report Q1, 2023 results on Aug 09, 2022Major Estimate Revision • Jun 09Consensus forecasts updatedThe consensus outlook for 2023 has been updated. 2023 revenue forecast increased from JP¥54.5b to JP¥64.5b. EPS estimate fell from JP¥98.90 to JP¥94.70. Net income forecast to grow 12% next year vs 6.0% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥1,700 to JP¥1,520. Share price rose 6.8% to JP¥1,226 over the past week.お知らせ • May 18Fumakilla Limited, Annual General Meeting, Jun 24, 2022Fumakilla Limited, Annual General Meeting, Jun 24, 2022.Reported Earnings • May 16Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2022 results: EPS: JP¥84.40 (down from JP¥141 in FY 2021). Revenue: JP¥52.7b (up 8.6% from FY 2021). Net income: JP¥1.39b (down 40% from FY 2021). Profit margin: 2.6% (down from 4.8% in FY 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) missed analyst estimates by 16%. Over the next year, revenue is forecast to grow 3.4%, compared to a 7.9% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.Price Target Changed • Apr 27Price target decreased to JP¥1,700Down from JP¥2,120, the current price target is provided by 1 analyst. New target price is 54% above last closing price of JP¥1,101. Stock is down 28% over the past year. The company is forecast to post earnings per share of JP¥100 for next year compared to JP¥141 last year.Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. 5 highly experienced directors. No independent directors (9 non-independent directors). General Manager of Production Division, Manager of Hiroshima Plant and Director Hiroaki Inoue was the last director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.お知らせ • Apr 08Fumakilla Limited to Report Fiscal Year 2022 Results on May 13, 2022Fumakilla Limited announced that they will report fiscal year 2022 results on May 13, 2022Upcoming Dividend • Mar 23Upcoming dividend of JP¥20.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 27 June 2022. Payout ratio is a comfortable 29% but the company is not cash flow positive. Trailing yield: 1.8%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%).Major Estimate Revision • Mar 17Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from JP¥49.5b to JP¥52.0b. EPS estimate fell from JP¥118 to JP¥100 per share. Net income forecast to grow 42% next year vs 2.4% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥2,120 to JP¥1,700. Share price rose 2.8% to JP¥1,107 over the past week.Reported Earnings • Feb 10Third quarter 2022 earnings: EPS and revenues miss analyst expectationsThird quarter 2022 results: JP¥46.84 loss per share (down from JP¥0.36 loss in 3Q 2021). Revenue: JP¥9.01b (up 18% from 3Q 2021). Net loss: JP¥772.0m (loss widened JP¥766.0m from 3Q 2021). Revenue missed analyst estimates by 2.0%. Earnings per share (EPS) were also behind analyst expectations. Over the next year, revenue is forecast to stay flat compared to a 6.5% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.お知らせ • Dec 24Fumakilla Limited (TSE:4998) agreed to acquire 80% stake in Zapi Industrie Chimiche Spa.Fumakilla Limited (TSE:4998) agreed to acquire 80% stake in Zapi Industrie Chimiche Spa on December 22, 2021. Fumakilla Limited will acquire 20,400 shares of Zapi owned by an individual and make the company a subsidiary.Major Estimate Revision • Dec 09Consensus EPS estimates fall to JP¥118The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from JP¥51.0b to JP¥49.5b. EPS estimate also fell from JP¥137 to JP¥118. Net income forecast to grow 5.6% next year vs 1.9% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥2,580 to JP¥2,120. Share price rose 2.3% to JP¥1,148 over the past week.Price Target Changed • Dec 08Price target decreased to JP¥2,120Down from JP¥2,530, the current price target is provided by 1 analyst. New target price is 82% above last closing price of JP¥1,165. Stock is down 24% over the past year. The company is forecast to post earnings per share of JP¥118 for next year compared to JP¥141 last year.Reported Earnings • Nov 15Second quarter 2022 earnings released: EPS JP¥4.19 (vs JP¥10.80 in 2Q 2021)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥10.8b (down 3.6% from 2Q 2021). Net income: JP¥69.0m (down 61% from 2Q 2021). Profit margin: 0.6% (down from 1.6% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.Reported Earnings • Aug 09First quarter 2022 earnings released: EPS JP¥69.65 (vs JP¥87.49 in 1Q 2021)The company reported a soft first quarter result with weaker earnings and profit margins, although revenues improved. First quarter 2022 results: Revenue: JP¥17.3b (up 11% from 1Q 2021). Net income: JP¥1.15b (down 20% from 1Q 2021). Profit margin: 6.6% (down from 9.3% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.Major Estimate Revision • Jun 09Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from JP¥155 to JP¥137. Revenue forecast unchanged from JP¥50.0b at last update. Net income forecast to shrink 3.1% next year vs 16% growth forecast for Chemicals industry in Japan . Consensus price target down from JP¥2,940 to JP¥2,530. Share price was steady at JP¥1,450 over the past week.Price Target Changed • Jun 08Price target decreased to JP¥2,530Down from JP¥2,860, the current price target is provided by 1 analyst. New target price is 75% above last closing price of JP¥1,443. Stock is down 27% over the past year.Reported Earnings • May 14Full year 2021 earnings released: EPS JP¥141 (vs JP¥46.72 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥48.5b (up 9.1% from FY 2020). Net income: JP¥2.32b (up 201% from FY 2020). Profit margin: 4.8% (up from 1.7% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings.Upcoming Dividend • Mar 23Upcoming dividend of JP¥22.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 29 June 2021. Trailing yield: 1.2%. Lower than top quartile of Japanese dividend payers (2.7%). Lower than average of industry peers (1.8%).Reported Earnings • Feb 14Third quarter 2021 earnings released: JP¥0.36 loss per share (vs JP¥41.68 loss in 3Q 2020)The company reported a solid third quarter result with reduced losses, improved revenues and improved control over expenses. Third quarter 2021 results: Revenue: JP¥7.65b (up 22% from 3Q 2020). Net loss: JP¥6.00m (loss narrowed 99% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.Is New 90 Day High Low • Feb 12New 90-day high: JP¥1,738The company is up 9.0% from its price of JP¥1,595 on 13 November 2020. The Japanese market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.Is New 90 Day High Low • Jan 22New 90-day high: JP¥1,722The company is up 6.0% from its price of JP¥1,631 on 23 October 2020. The Japanese market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period.お知らせ • Dec 30Fumakilla Limited to Report Q3, 2021 Results on Feb 12, 2021Fumakilla Limited announced that they will report Q3, 2021 results on Feb 12, 2021Major Estimate Revision • Dec 15Analysts increase EPS estimates to JP¥164The 2021 consensus revenue estimate increased from JP¥47.0b to JP¥49.5b. The earnings per share estimate also received an upgrade from JP¥134 to JP¥164 for the same period. Net income is expected to shrink by 0.5% next year compared to 13% growth forecast for the Chemicals industry in Japan . The consensus price target increased from JP¥2,860 to JP¥2,940. Share price is up 6.0% to JP¥1,599 over the past week.Price Target Changed • Dec 01Price target raised to JP¥2,860Up from JP¥2,300, the current price target is provided by 1 analyst. The new target price is 90% above the current share price of JP¥1,505. As of last close, the stock is up 25% over the past year.お知らせ • Sep 06Fumakilla Limited to Report Q2, 2021 Results on Nov 13, 2020Fumakilla Limited announced that they will report Q2, 2021 results on Nov 13, 2020お知らせ • Jul 26Fumakilla Limited to Report Q1, 2021 Results on Aug 07, 2020Fumakilla Limited announced that they will report Q1, 2021 results on Aug 07, 2020収支内訳Fumakilla の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。収益と収入の歴史TSE:4998 収益、費用、利益 ( )JPY Millions日付収益収益G+A経費研究開発費31 Mar 2677,3661,20621,044031 Dec 2575,3701,83520,329030 Sep 2573,4462,04619,422030 Jun 2573,7691,28319,467031 Mar 2573,8541,46219,253031 Dec 2470,7731,55118,086030 Sep 2471,1321,22218,094030 Jun 2469,4021,59017,787031 Mar 2467,6721,37717,063031 Dec 2365,6521,46616,043030 Sep 2364,27598215,698030 Jun 2362,39170215,356031 Mar 2361,71266815,375031 Dec 2261,95818515,975030 Sep 2259,10375715,161030 Jun 2253,91470513,903031 Mar 2252,7291,39113,177031 Dec 2151,2231,15213,310030 Sep 2149,8591,91812,954030 Jun 2150,2672,02712,546031 Mar 2148,5322,32111,741031 Dec 2049,7573,32011,066030 Sep 2048,3992,63910,640030 Jun 2046,7272,05010,539031 Mar 2044,48577011,038031 Dec 1943,10131710,541030 Sep 1942,12138910,589030 Jun 1940,72854110,509031 Mar 1941,24369310,768031 Dec 1843,63971312,330030 Sep 1844,96575013,120030 Jun 1846,99788213,764031 Mar 1847,7401,73513,193031 Dec 1746,3151,10312,904030 Sep 1744,9431,12512,319030 Jun 1742,9071,27811,597031 Mar 1742,3621,38711,233031 Dec 1639,8781,46110,124030 Sep 1637,5971,4369,385030 Jun 1637,3801,3759,369031 Mar 1636,2881,1319,332031 Dec 1534,7318489,353030 Sep 1536,2339739,691030 Jun 1534,9749959,3700質の高い収益: 4998は 高品質の収益 を持っています。利益率の向上: 4998の現在の純利益率 (1.6%)は、昨年(2%)よりも低くなっています。フリー・キャッシュフローと収益の比較過去の収益成長分析収益動向: 4998の収益は過去 5 年間で年間0.8%増加しました。成長の加速: 4998は過去 1 年間の収益成長がマイナスであったため、5 年間の平均と比較することはできません。収益対業界: 4998は過去 1 年間で収益成長率がマイナス ( -17.5% ) となったため、 Chemicals業界平均 ( 11% ) と比較することが困難です。株主資本利益率高いROE: 4998の 自己資本利益率 ( 4.8% ) は 低い とみなされます。総資産利益率使用総資本利益率過去の好業績企業の発掘7D1Y7D1Y7D1YMaterials 、過去の業績が好調な企業。View Financial Health企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/14 23:26終値2026/06/12 00:00収益2026/03/31年間収益2026/03/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Fumakilla Limited 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Yasuhiro NaritaNomura Securities Co. Ltd.
Reported Earnings • May 18Full year 2026 earnings released: EPS: JP¥73.18 (vs JP¥88.72 in FY 2025)Full year 2026 results: EPS: JP¥73.18 (down from JP¥88.72 in FY 2025). Revenue: JP¥77.4b (up 4.8% from FY 2025). Net income: JP¥1.21b (down 18% from FY 2025). Profit margin: 1.6% (down from 2.0% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
お知らせ • May 09Fumakilla Limited to Report Fiscal Year 2026 Results on May 14, 2026Fumakilla Limited announced that they will report fiscal year 2026 results on May 14, 2026
Reported Earnings • Feb 11Third quarter 2026 earnings released: JP¥45.02 loss per share (vs JP¥32.22 loss in 3Q 2025)Third quarter 2026 results: JP¥45.02 loss per share (further deteriorated from JP¥32.22 loss in 3Q 2025). Revenue: JP¥14.8b (up 15% from 3Q 2025). Net loss: JP¥742.0m (loss widened 40% from 3Q 2025). Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
Reported Earnings • Nov 12Second quarter 2026 earnings released: EPS: JP¥48.30 (vs JP¥2.00 in 2Q 2025)Second quarter 2026 results: EPS: JP¥48.30 (up from JP¥2.00 in 2Q 2025). Revenue: JP¥19.3b (down 1.6% from 2Q 2025). Net income: JP¥796.0m (up JP¥763.0m from 2Q 2025). Profit margin: 4.1% (up from 0.2% in 2Q 2025). The increase in margin was driven by lower expenses. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
お知らせ • Oct 02Fumakilla Limited to Report Q2, 2026 Results on Nov 10, 2025Fumakilla Limited announced that they will report Q2, 2026 results on Nov 10, 2025
Reported Earnings • Aug 10First quarter 2026 earnings released: EPS: JP¥32.16 (vs JP¥43.02 in 1Q 2025)First quarter 2026 results: EPS: JP¥32.16 (down from JP¥43.02 in 1Q 2025). Revenue: JP¥20.8b (flat on 1Q 2025). Net income: JP¥530.0m (down 25% from 1Q 2025). Profit margin: 2.5% (down from 3.4% in 1Q 2025). Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
Reported Earnings • May 18Full year 2026 earnings released: EPS: JP¥73.18 (vs JP¥88.72 in FY 2025)Full year 2026 results: EPS: JP¥73.18 (down from JP¥88.72 in FY 2025). Revenue: JP¥77.4b (up 4.8% from FY 2025). Net income: JP¥1.21b (down 18% from FY 2025). Profit margin: 1.6% (down from 2.0% in FY 2025). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 21% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
お知らせ • May 14Fumakilla Limited, Annual General Meeting, Jun 26, 2026Fumakilla Limited, Annual General Meeting, Jun 26, 2026.
お知らせ • May 09Fumakilla Limited to Report Fiscal Year 2026 Results on May 14, 2026Fumakilla Limited announced that they will report fiscal year 2026 results on May 14, 2026
Upcoming Dividend • Mar 23Upcoming dividend of JP¥24.00 per shareEligible shareholders must have bought the stock before 30 March 2026. Payment date: 30 June 2026. Payout ratio is a comfortable 20% but the company is not cash flow positive. Trailing yield: 2.1%. Lower than top quartile of Japanese dividend payers (3.6%). In line with average of industry peers (2.3%).
New Risk • Feb 28New major risk - Revenue and earnings growthEarnings have declined by 6.0% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 6.0% per year over the past 5 years. Minor Risk Paying a dividend despite having no free cash flows.
Reported Earnings • Feb 11Third quarter 2026 earnings released: JP¥45.02 loss per share (vs JP¥32.22 loss in 3Q 2025)Third quarter 2026 results: JP¥45.02 loss per share (further deteriorated from JP¥32.22 loss in 3Q 2025). Revenue: JP¥14.8b (up 15% from 3Q 2025). Net loss: JP¥742.0m (loss widened 40% from 3Q 2025). Revenue is forecast to grow 4.4% p.a. on average during the next 3 years, compared to a 4.4% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 36% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
分析記事 • Jan 08Fumakilla (TSE:4998) Has Announced That It Will Be Increasing Its Dividend To ¥24.00Fumakilla Limited ( TSE:4998 ) has announced that it will be increasing its dividend from last year's comparable...
Declared Dividend • Jan 08Dividend of JP¥24.00 announcedShareholders will receive a dividend of JP¥24.00. Ex-date: 30th March 2026 Payment date: 30th June 2026 Dividend yield will be 2.1%, which is lower than the industry average of 2.2%. Sustainability & Growth Dividend is covered by earnings (18% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 4.1% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 39% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
お知らせ • Jan 07Fumakilla Limited announces Annual dividend, payable on June 30, 2026Fumakilla Limited announced Annual dividend of JPY 24.0000 per share payable on June 30, 2026, ex-date on March 30, 2026 and record date on March 31, 2026.
Reported Earnings • Nov 12Second quarter 2026 earnings released: EPS: JP¥48.30 (vs JP¥2.00 in 2Q 2025)Second quarter 2026 results: EPS: JP¥48.30 (up from JP¥2.00 in 2Q 2025). Revenue: JP¥19.3b (down 1.6% from 2Q 2025). Net income: JP¥796.0m (up JP¥763.0m from 2Q 2025). Profit margin: 4.1% (up from 0.2% in 2Q 2025). The increase in margin was driven by lower expenses. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has only increased by 4% per year, which means it is significantly lagging earnings growth.
お知らせ • Oct 02Fumakilla Limited to Report Q2, 2026 Results on Nov 10, 2025Fumakilla Limited announced that they will report Q2, 2026 results on Nov 10, 2025
Reported Earnings • Aug 10First quarter 2026 earnings released: EPS: JP¥32.16 (vs JP¥43.02 in 1Q 2025)First quarter 2026 results: EPS: JP¥32.16 (down from JP¥43.02 in 1Q 2025). Revenue: JP¥20.8b (flat on 1Q 2025). Net income: JP¥530.0m (down 25% from 1Q 2025). Profit margin: 2.5% (down from 3.4% in 1Q 2025). Revenue is forecast to grow 4.3% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth.
お知らせ • Jun 29Fumakilla Limited to Report Q1, 2026 Results on Aug 08, 2025Fumakilla Limited announced that they will report Q1, 2026 results on Aug 08, 2025
Reported Earnings • May 18Full year 2025 earnings: EPS misses analyst expectationsFull year 2025 results: EPS: JP¥88.72 (up from JP¥83.56 in FY 2024). Revenue: JP¥73.9b (up 9.1% from FY 2024). Net income: JP¥1.46b (up 6.2% from FY 2024). Profit margin: 2.0% (in line with FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 11%. Revenue is forecast to grow 5.3% p.a. on average during the next 2 years, compared to a 4.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 26% per year but the company’s share price has remained flat, which means it is significantly lagging earnings.
お知らせ • May 14Fumakilla Limited, Annual General Meeting, Jun 27, 2025Fumakilla Limited, Annual General Meeting, Jun 27, 2025.
お知らせ • May 01Fumakilla Limited to Report Fiscal Year 2025 Results on May 14, 2025Fumakilla Limited announced that they will report fiscal year 2025 results on May 14, 2025
Upcoming Dividend • Mar 21Upcoming dividend of JP¥22.00 per shareEligible shareholders must have bought the stock before 28 March 2025. Payment date: 28 June 2025. Payout ratio is a comfortable 23% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of Japanese dividend payers (3.7%). Lower than average of industry peers (2.6%).
Reported Earnings • Feb 12Third quarter 2025 earnings released: JP¥32.22 loss per share (vs JP¥52.18 loss in 3Q 2024)Third quarter 2025 results: JP¥32.22 loss per share (improved from JP¥52.18 loss in 3Q 2024). Revenue: JP¥12.9b (down 2.7% from 3Q 2024). Net loss: JP¥531.0m (loss narrowed 38% from 3Q 2024). Revenue is forecast to grow 6.2% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 20% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
お知らせ • Jan 17Fumakilla Limited to Report Q3, 2025 Results on Feb 10, 2025Fumakilla Limited announced that they will report Q3, 2025 results on Feb 10, 2025
Reported Earnings • Nov 10Second quarter 2025 earnings released: EPS: JP¥2.00 (vs JP¥24.33 in 2Q 2024)Second quarter 2025 results: EPS: JP¥2.00 (down from JP¥24.33 in 2Q 2024). Revenue: JP¥19.6b (up 9.7% from 2Q 2024). Net income: JP¥33.0m (down 92% from 2Q 2024). Profit margin: 0.2% (down from 2.2% in 2Q 2024). The decrease in margin was driven by higher expenses. Revenue is forecast to grow 4.6% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
お知らせ • Sep 28Fumakilla Limited to Report Q2, 2025 Results on Nov 08, 2024Fumakilla Limited announced that they will report Q2, 2025 results on Nov 08, 2024
Reported Earnings • Aug 13First quarter 2025 earnings released: EPS: JP¥43.02 (vs JP¥30.10 in 1Q 2024)First quarter 2025 results: EPS: JP¥43.02 (up from JP¥30.10 in 1Q 2024). Revenue: JP¥20.9b (up 9.0% from 1Q 2024). Net income: JP¥709.0m (up 43% from 1Q 2024). Profit margin: 3.4% (up from 2.6% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 5.6% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 10% per year whereas the company’s share price has fallen by 8% per year.
お知らせ • Jun 30Fumakilla Limited to Report Q1, 2025 Results on Aug 09, 2024Fumakilla Limited announced that they will report Q1, 2025 results on Aug 09, 2024
Major Estimate Revision • Jun 22Consensus EPS estimates fall by 13%, revenue upgradedThe consensus outlook for fiscal year 2025 has been updated. 2025 revenue forecast increased from JP¥69.4b to JP¥75.0b. EPS estimate fell from JP¥115 to JP¥100 per share. Net income forecast to grow 20% next year vs 11% growth forecast for Chemicals industry in Japan. Consensus price target up from JP¥1,365 to JP¥1,500. Share price was steady at JP¥1,198 over the past week.
Price Target Changed • Jun 21Price target increased by 14% to JP¥1,500Up from JP¥1,320, the current price target is provided by 1 analyst. New target price is 25% above last closing price of JP¥1,198. Stock is up 5.7% over the past year. The company is forecast to post earnings per share of JP¥100 for next year compared to JP¥83.55 last year.
Reported Earnings • May 21Full year 2024 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2024 results: EPS: JP¥83.55 (up from JP¥40.53 in FY 2023). Revenue: JP¥67.7b (up 9.7% from FY 2023). Net income: JP¥1.38b (up 106% from FY 2023). Profit margin: 2.0% (up from 1.1% in FY 2023). The increase in margin was driven by higher revenue. Revenue exceeded analyst estimates by 1.0%. Earnings per share (EPS) missed analyst estimates by 8.2%. Revenue is forecast to grow 2.7% p.a. on average during the next 2 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 28% per year but the company’s share price has only fallen by 5% per year, which means it has not declined as severely as earnings.
New Risk • May 21New major risk - Revenue and earnings growthEarnings have declined by 3.2% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risk Earnings have declined by 3.2% per year over the past 5 years. Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
お知らせ • May 17Fumakilla Limited, Annual General Meeting, Jun 27, 2024Fumakilla Limited, Annual General Meeting, Jun 27, 2024.
お知らせ • Mar 28Fumakilla Limited to Report Fiscal Year 2024 Results on May 15, 2024Fumakilla Limited announced that they will report fiscal year 2024 results on May 15, 2024
Upcoming Dividend • Mar 21Upcoming dividend of JP¥22.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 01 July 2024. Payout ratio is a comfortable 25% and this is well supported by cash flows. Trailing yield: 1.9%. Lower than top quartile of Japanese dividend payers (3.2%). In line with average of industry peers (2.1%).
Reported Earnings • Feb 10Third quarter 2024 earnings released: JP¥52.18 loss per share (vs JP¥81.55 loss in 3Q 2023)Third quarter 2024 results: JP¥52.18 loss per share (improved from JP¥81.55 loss in 3Q 2023). Revenue: JP¥13.2b (up 12% from 3Q 2023). Net loss: JP¥860.0m (loss narrowed 36% from 3Q 2023). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
Reported Earnings • Feb 10Third quarter 2024 earnings released: JP¥52.18 loss per share (vs JP¥81.55 loss in 3Q 2023)Third quarter 2024 results: JP¥52.18 loss per share (improved from JP¥81.55 loss in 3Q 2023). Revenue: JP¥13.2b (up 12% from 3Q 2023). Net loss: JP¥860.0m (loss narrowed 36% from 3Q 2023). Revenue is forecast to grow 3.6% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 48% per year but the company’s share price has only fallen by 12% per year, which means it has not declined as severely as earnings.
お知らせ • Jan 31Fumakilla Limited to Report Q3, 2024 Results on Feb 09, 2024Fumakilla Limited announced that they will report Q3, 2024 results on Feb 09, 2024
Reported Earnings • Nov 11Second quarter 2024 earnings released: EPS: JP¥24.33 (vs JP¥7.34 in 2Q 2023)Second quarter 2024 results: EPS: JP¥24.33 (up from JP¥7.34 in 2Q 2023). Revenue: JP¥17.9b (up 12% from 2Q 2023). Net income: JP¥401.0m (up 231% from 2Q 2023). Profit margin: 2.2% (up from 0.8% in 2Q 2023). The increase in margin was driven by higher revenue. Revenue is forecast to grow 2.4% p.a. on average during the next 3 years, compared to a 5.0% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 58% per year but the company’s share price has only fallen by 13% per year, which means it has not declined as severely as earnings.
お知らせ • Oct 05Fumakilla Limited to Report Q2, 2024 Results on Nov 10, 2023Fumakilla Limited announced that they will report Q2, 2024 results on Nov 10, 2023
Major Estimate Revision • Aug 25Consensus EPS estimates fall by 17%The consensus outlook for fiscal year 2024 has been updated. 2024 EPS estimate fell from JP¥106 to JP¥88.00 per share. Revenue forecast steady at JP¥64.5b. Net income forecast to grow 117% next year vs 7.6% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥1,480 to JP¥1,320. Share price rose 2.5% to JP¥1,107 over the past week.
Reported Earnings • Aug 12First quarter 2024 earnings released: EPS: JP¥30.10 (vs JP¥28.03 in 1Q 2023)First quarter 2024 results: EPS: JP¥30.10 (up from JP¥28.03 in 1Q 2023). Revenue: JP¥19.2b (up 3.7% from 1Q 2023). Net income: JP¥496.0m (up 7.4% from 1Q 2023). Profit margin: 2.6% (in line with 1Q 2023). Revenue is forecast to grow 3.0% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has only fallen by 15% per year, which means it has not declined as severely as earnings.
Buying Opportunity • Aug 10Now 24% undervaluedOver the last 90 days, the stock is up 3.5%. The fair value is estimated to be JP¥1,464, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 10% over the last 3 years. Earnings per share has declined by 40%. For the next 3 years, revenue is forecast to grow by 3.1% per annum. Earnings is also forecast to grow by 28% per annum over the same time period.
お知らせ • Jul 10Fumakilla Limited to Report Q1, 2024 Results on Aug 10, 2023Fumakilla Limited announced that they will report Q1, 2024 results on Aug 10, 2023
Reported Earnings • May 21Full year 2023 earnings: EPS and revenues miss analyst expectationsFull year 2023 results: EPS: JP¥40.53 (down from JP¥84.40 in FY 2022). Revenue: JP¥61.7b (up 17% from FY 2022). Net income: JP¥668.0m (down 52% from FY 2022). Profit margin: 1.1% (down from 2.6% in FY 2022). Revenue missed analyst estimates by 4.3%. Earnings per share (EPS) also missed analyst estimates by 33%. Revenue is forecast to grow 6.2% p.a. on average during the next 2 years, compared to a 3.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 40% per year but the company’s share price has only fallen by 11% per year, which means it has not declined as severely as earnings.
お知らせ • May 14Fumakilla Limited, Annual General Meeting, May 15, 2023Fumakilla Limited, Annual General Meeting, May 15, 2023.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥22.00 per share at 2.1% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 27 June 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 2.1%. Lower than top quartile of Japanese dividend payers (3.6%). Lower than average of industry peers (2.8%).
Reported Earnings • Feb 17Third quarter 2023 earnings released: JP¥81.54 loss per share (vs JP¥46.84 loss in 3Q 2022)Third quarter 2023 results: JP¥81.54 loss per share (further deteriorated from JP¥46.84 loss in 3Q 2022). Revenue: JP¥11.9b (up 32% from 3Q 2022). Net loss: JP¥1.34b (loss widened 74% from 3Q 2022). Revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 22% per year but the company’s share price has only fallen by 10% per year, which means it has not declined as severely as earnings.
お知らせ • Dec 31Fumakilla Limited to Report Q3, 2023 Results on Feb 10, 2023Fumakilla Limited announced that they will report Q3, 2023 results on Feb 10, 2023
Major Estimate Revision • Dec 23Consensus forecasts updatedThe consensus outlook for 2023 has been updated. 2023 revenue forecast increased from JP¥63.0b to JP¥64.5b. EPS estimate fell from JP¥77.10 to JP¥60.70 per share. Net income forecast to grow 82% next year vs 0.7% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥1,310 to JP¥1,200. Share price was steady at JP¥1,034 over the past week.
Reported Earnings • Nov 16Second quarter 2023 earnings released: EPS: JP¥7.34 (vs JP¥4.19 in 2Q 2022)Second quarter 2023 results: EPS: JP¥7.34 (up from JP¥4.19 in 2Q 2022). Revenue: JP¥16.0b (up 48% from 2Q 2022). Net income: JP¥121.0m (up 75% from 2Q 2022). Profit margin: 0.8% (up from 0.6% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.1% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Board Change • Nov 16No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. 5 highly experienced directors. No independent directors (11 non-independent directors). General Manager of Production Division, Manager of Hiroshima Plant and Director Hiroaki Inoue was the last director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
Reported Earnings • Nov 13Second quarter 2023 earnings released: EPS: JP¥7.34 (vs JP¥4.19 in 2Q 2022)Second quarter 2023 results: EPS: JP¥7.34 (up from JP¥4.19 in 2Q 2022). Revenue: JP¥16.0b (up 48% from 2Q 2022). Net income: JP¥121.0m (up 75% from 2Q 2022). Profit margin: 0.8% (up from 0.6% in 2Q 2022). The increase in margin was driven by higher revenue. Revenue is forecast to grow 6.1% p.a. on average during the next 3 years, compared to a 4.3% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
お知らせ • Sep 03Fumakilla Limited to Report Q2, 2023 Results on Nov 11, 2022Fumakilla Limited announced that they will report Q2, 2023 results on Nov 11, 2022
Major Estimate Revision • Aug 30Consensus EPS estimates fall by 19%The consensus outlook for earnings per share (EPS) in 2023 has deteriorated. 2023 revenue forecast decreased from JP¥64.5b to JP¥63.0b. EPS estimate also fell from JP¥94.70 per share to JP¥77.10 per share. Net income forecast to grow 104% next year vs 2.5% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥1,520 to JP¥1,310. Share price was steady at JP¥1,095 over the past week.
Reported Earnings • Aug 11First quarter 2023 earnings released: EPS: JP¥28.03 (vs JP¥69.66 in 1Q 2022)First quarter 2023 results: EPS: JP¥28.03 (down from JP¥69.66 in 1Q 2022). Revenue: JP¥18.5b (up 6.8% from 1Q 2022). Net income: JP¥462.0m (down 60% from 1Q 2022). Profit margin: 2.5% (down from 6.6% in 1Q 2022). The decrease in margin was driven by higher expenses. Over the next year, revenue is forecast to grow 21%, compared to a 9.2% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has fallen by 1% per year, which means it is significantly lagging earnings.
お知らせ • Jul 02Fumakilla Limited to Report Q1, 2023 Results on Aug 09, 2022Fumakilla Limited announced that they will report Q1, 2023 results on Aug 09, 2022
Major Estimate Revision • Jun 09Consensus forecasts updatedThe consensus outlook for 2023 has been updated. 2023 revenue forecast increased from JP¥54.5b to JP¥64.5b. EPS estimate fell from JP¥98.90 to JP¥94.70. Net income forecast to grow 12% next year vs 6.0% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥1,700 to JP¥1,520. Share price rose 6.8% to JP¥1,226 over the past week.
お知らせ • May 18Fumakilla Limited, Annual General Meeting, Jun 24, 2022Fumakilla Limited, Annual General Meeting, Jun 24, 2022.
Reported Earnings • May 16Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behindFull year 2022 results: EPS: JP¥84.40 (down from JP¥141 in FY 2021). Revenue: JP¥52.7b (up 8.6% from FY 2021). Net income: JP¥1.39b (down 40% from FY 2021). Profit margin: 2.6% (down from 4.8% in FY 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 1.4%. Earnings per share (EPS) missed analyst estimates by 16%. Over the next year, revenue is forecast to grow 3.4%, compared to a 7.9% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 33% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
Price Target Changed • Apr 27Price target decreased to JP¥1,700Down from JP¥2,120, the current price target is provided by 1 analyst. New target price is 54% above last closing price of JP¥1,101. Stock is down 28% over the past year. The company is forecast to post earnings per share of JP¥100 for next year compared to JP¥141 last year.
Board Change • Apr 27No independent directorsNo new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. 5 highly experienced directors. No independent directors (9 non-independent directors). General Manager of Production Division, Manager of Hiroshima Plant and Director Hiroaki Inoue was the last director to join the board, commencing their role in 2013. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment.
お知らせ • Apr 08Fumakilla Limited to Report Fiscal Year 2022 Results on May 13, 2022Fumakilla Limited announced that they will report fiscal year 2022 results on May 13, 2022
Upcoming Dividend • Mar 23Upcoming dividend of JP¥20.00 per shareEligible shareholders must have bought the stock before 30 March 2022. Payment date: 27 June 2022. Payout ratio is a comfortable 29% but the company is not cash flow positive. Trailing yield: 1.8%. Lower than top quartile of Japanese dividend payers (3.4%). Lower than average of industry peers (2.6%).
Major Estimate Revision • Mar 17Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 revenue forecast increased from JP¥49.5b to JP¥52.0b. EPS estimate fell from JP¥118 to JP¥100 per share. Net income forecast to grow 42% next year vs 2.4% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥2,120 to JP¥1,700. Share price rose 2.8% to JP¥1,107 over the past week.
Reported Earnings • Feb 10Third quarter 2022 earnings: EPS and revenues miss analyst expectationsThird quarter 2022 results: JP¥46.84 loss per share (down from JP¥0.36 loss in 3Q 2021). Revenue: JP¥9.01b (up 18% from 3Q 2021). Net loss: JP¥772.0m (loss widened JP¥766.0m from 3Q 2021). Revenue missed analyst estimates by 2.0%. Earnings per share (EPS) were also behind analyst expectations. Over the next year, revenue is forecast to stay flat compared to a 6.5% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 43% per year but the company’s share price has fallen by 4% per year, which means it is significantly lagging earnings.
お知らせ • Dec 24Fumakilla Limited (TSE:4998) agreed to acquire 80% stake in Zapi Industrie Chimiche Spa.Fumakilla Limited (TSE:4998) agreed to acquire 80% stake in Zapi Industrie Chimiche Spa on December 22, 2021. Fumakilla Limited will acquire 20,400 shares of Zapi owned by an individual and make the company a subsidiary.
Major Estimate Revision • Dec 09Consensus EPS estimates fall to JP¥118The consensus outlook for earnings per share (EPS) in 2022 has deteriorated. 2022 revenue forecast decreased from JP¥51.0b to JP¥49.5b. EPS estimate also fell from JP¥137 to JP¥118. Net income forecast to grow 5.6% next year vs 1.9% growth forecast for Chemicals industry in Japan. Consensus price target down from JP¥2,580 to JP¥2,120. Share price rose 2.3% to JP¥1,148 over the past week.
Price Target Changed • Dec 08Price target decreased to JP¥2,120Down from JP¥2,530, the current price target is provided by 1 analyst. New target price is 82% above last closing price of JP¥1,165. Stock is down 24% over the past year. The company is forecast to post earnings per share of JP¥118 for next year compared to JP¥141 last year.
Reported Earnings • Nov 15Second quarter 2022 earnings released: EPS JP¥4.19 (vs JP¥10.80 in 2Q 2021)The company reported a poor second quarter result with weaker earnings, revenues and profit margins. Second quarter 2022 results: Revenue: JP¥10.8b (down 3.6% from 2Q 2021). Net income: JP¥69.0m (down 61% from 2Q 2021). Profit margin: 0.6% (down from 1.6% in 2Q 2021). The decrease in margin was driven by lower revenue. Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has fallen by 8% per year, which means it is significantly lagging earnings.
Reported Earnings • Aug 09First quarter 2022 earnings released: EPS JP¥69.65 (vs JP¥87.49 in 1Q 2021)The company reported a soft first quarter result with weaker earnings and profit margins, although revenues improved. First quarter 2022 results: Revenue: JP¥17.3b (up 11% from 1Q 2021). Net income: JP¥1.15b (down 20% from 1Q 2021). Profit margin: 6.6% (down from 9.3% in 1Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 54% per year but the company’s share price has fallen by 6% per year, which means it is significantly lagging earnings.
Major Estimate Revision • Jun 09Consensus forecasts updatedThe consensus outlook for 2022 has been updated. 2022 EPS estimate fell from JP¥155 to JP¥137. Revenue forecast unchanged from JP¥50.0b at last update. Net income forecast to shrink 3.1% next year vs 16% growth forecast for Chemicals industry in Japan . Consensus price target down from JP¥2,940 to JP¥2,530. Share price was steady at JP¥1,450 over the past week.
Price Target Changed • Jun 08Price target decreased to JP¥2,530Down from JP¥2,860, the current price target is provided by 1 analyst. New target price is 75% above last closing price of JP¥1,443. Stock is down 27% over the past year.
Reported Earnings • May 14Full year 2021 earnings released: EPS JP¥141 (vs JP¥46.72 in FY 2020)The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: JP¥48.5b (up 9.1% from FY 2020). Net income: JP¥2.32b (up 201% from FY 2020). Profit margin: 4.8% (up from 1.7% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 40% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥22.00 per shareEligible shareholders must have bought the stock before 30 March 2021. Payment date: 29 June 2021. Trailing yield: 1.2%. Lower than top quartile of Japanese dividend payers (2.7%). Lower than average of industry peers (1.8%).
Reported Earnings • Feb 14Third quarter 2021 earnings released: JP¥0.36 loss per share (vs JP¥41.68 loss in 3Q 2020)The company reported a solid third quarter result with reduced losses, improved revenues and improved control over expenses. Third quarter 2021 results: Revenue: JP¥7.65b (up 22% from 3Q 2020). Net loss: JP¥6.00m (loss narrowed 99% from 3Q 2020). Over the last 3 years on average, earnings per share has increased by 31% per year but the company’s share price has fallen by 10% per year, which means it is significantly lagging earnings.
Is New 90 Day High Low • Feb 12New 90-day high: JP¥1,738The company is up 9.0% from its price of JP¥1,595 on 13 November 2020. The Japanese market is up 13% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 14% over the same period.
Is New 90 Day High Low • Jan 22New 90-day high: JP¥1,722The company is up 6.0% from its price of JP¥1,631 on 23 October 2020. The Japanese market is up 14% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Chemicals industry, which is up 17% over the same period.
お知らせ • Dec 30Fumakilla Limited to Report Q3, 2021 Results on Feb 12, 2021Fumakilla Limited announced that they will report Q3, 2021 results on Feb 12, 2021
Major Estimate Revision • Dec 15Analysts increase EPS estimates to JP¥164The 2021 consensus revenue estimate increased from JP¥47.0b to JP¥49.5b. The earnings per share estimate also received an upgrade from JP¥134 to JP¥164 for the same period. Net income is expected to shrink by 0.5% next year compared to 13% growth forecast for the Chemicals industry in Japan . The consensus price target increased from JP¥2,860 to JP¥2,940. Share price is up 6.0% to JP¥1,599 over the past week.
Price Target Changed • Dec 01Price target raised to JP¥2,860Up from JP¥2,300, the current price target is provided by 1 analyst. The new target price is 90% above the current share price of JP¥1,505. As of last close, the stock is up 25% over the past year.
お知らせ • Sep 06Fumakilla Limited to Report Q2, 2021 Results on Nov 13, 2020Fumakilla Limited announced that they will report Q2, 2021 results on Nov 13, 2020
お知らせ • Jul 26Fumakilla Limited to Report Q1, 2021 Results on Aug 07, 2020Fumakilla Limited announced that they will report Q1, 2021 results on Aug 07, 2020